Inhibitors of Akt activity

Details for Australian Patent Application No. 2006216998 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Zhao, Zhijian; Sanderson, Philip E.; Lindsley, Craig W.; Cosford, Nicholas D. P.; Liang, Jun; Layton, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-B-2006216998

PCT Pub. Number WO2006/091395

Priority 60/652,737 14.02.05 US

Filing date 10 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 23 December 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/091395 Priority application(s): WO2006/091395

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

23 December 2010 Application Accepted

  Published as AU-B-2006216998

21 April 2011 Standard Patent Sealed

6 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006217000-Acetic acid production methods incorporating at least one metal salt as a catalyst stabilizer

2006216997-Substituted imidazoquinolines and imidazonaphthyridines